KIR genotype distribution among symptomatic patients with and without Helicobacter pylori infection: Is there any role for the B haplotype?
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Publishing Group
Abstract
Contact of peripheral blood lymphocytes with Helicobacter pylori was proved to induce non- major histocompatibility complex-restricted cytotoxicity and natural killer cells are thought to play an important role in the immunity against H. pylori.; Aims: In this research, we investigated any possible association between killer immunoglobulin-like receptors (KIR) genotypes and H. pylori infection.; Methods: KIR genotype was analysed in 101 Lebanese symptomatic patients (51 H. pylori positive and 50 H. pylori-negative) using the KIR Genotyping SSP kit.; Results: Among the H. pylori-positive patients, the AA, AB and BB genotypical frequencies were, respectively, 43.14%, 41.18% and 15.68% with an A:B ratio of 1.76:1. The AA, AB and BB genotypes frequencies for H. pylori-negative individuals were 18%, 62% and 20%, respectively, with an A:B ratio of 0.96:1. No significant difference between patients and controls was detected.; Conclusions: We noticed a reduced distribution of A haplotype among the 'H. pylori-negative' patients as compared with the H. pylori-positive group. This is the first study in the international literature that targets the correlation between KIR genotypes and H. pylori.
Description
Keywords
Genetic predisposition to disease, Genotype, Helicobacter infections, Helicobacter pylori, Humans, Lebanon, Receptors, kir, Reverse transcriptase polymerase chain reaction, Killer cell immunoglobulin like receptor, Taq polymerase, Article, Controlled study, Dna extraction, Gene expression, Gene frequency, Gene locus, Genetic analysis, Genetic variability, Haplotype, Helicobacter infection, Human, Infection sensitivity, Lebanese, Major clinical study, Natural killer cell, Nonhuman, Phenotype, Protein expression, Genetic predisposition, Genetics, Immunology, Reverse transcription polymerase chain reaction